A Randomized, Double-blind, Active-controlled, Multi-center, Parallel-group Dose-ranging Study Assessing the Safety and Efficacy of EPB-348 Versus Valacyclovir Among Immunocompetent Patients With an Acute Episode of Herpes Zoster

Trial Profile

A Randomized, Double-blind, Active-controlled, Multi-center, Parallel-group Dose-ranging Study Assessing the Safety and Efficacy of EPB-348 Versus Valacyclovir Among Immunocompetent Patients With an Acute Episode of Herpes Zoster

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Dec 2013

At a glance

  • Drugs Valomaciclovir (Primary) ; Valaciclovir
  • Indications Herpes zoster
  • Focus Therapeutic Use
  • Sponsors Epiphany Biosciences
  • Most Recent Events

    • 13 Sep 2010 Results were presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    • 20 Nov 2009 Status changed from recruiting to completed.
    • 20 Nov 2009 Primary endpoint 'Time-to-resolution-of-symptoms' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top